SCHEMBL4842635

SCHEMBL4842635

O=C(O)c1ccc(CCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3cccc(C(F)(F)F)c3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 4/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
MMP8 P22894 2/20 0.41
MMP3 P08254 1/20 0.41
GPBAR1 Q8TDU6 1/20 0.40
PTGER4 P35408 1/20 0.40
PTGER2 P43116 1/20 0.40
FKBP1A P62942 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPK1 P28482 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
S1PR5 Q9H228 1/20 0.40
SLC13A5 Q86YT5 1/20 0.40
ADAMTS7 Q9UKP4 1/20 0.39
ADAMTS5 Q9UNA0 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4845228 0.93 RORC (0.41) RORCCA12CA1CA2CA9
SCHEMBL4842554 0.92 RORC (0.43) RORCCA12CA1CA2CA9
SCHEMBL4842556 0.92 RORC (0.43) RORCCA12CA1CA2CA9
SCHEMBL4844942 0.92 RORC (0.43) RORCMMP8MMP3PTGER4S1PR5
SCHEMBL4211574 0.90 MMP8 (0.41) RORCCA12CA1CA2CA9
SCHEMBL4840319 0.89 RORC (0.43) RORCMMP8MMP3ALDH1A1NPSR1
SCHEMBL4845363 0.89 RORC (0.43) RORCMMP8MMP3
SCHEMBL4844926 0.88 RORC (0.42) RORCMMP8MMP3FKBP1AS1PR5
SCHEMBL4843243 0.88 RORC (0.42) RORCCA12CA1CA2CA9
SCHEMBL4833738 0.88 PTPN1 (0.39) RORCCA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 RORC 1777/4885CA12 4875/4885CA1 4641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.